Valuation: Sanofi

Market Cap 91.84B 106B 86.16B 78.48B 148B 10,172B 150B 1,010B 396B 5,096B 399B 391B 16,952B P/E 2026 *
12.2x
P/E 2027 * 10.6x
Enterprise Value 103B 120B 96.87B 88.23B 166B 11,436B 168B 1,136B 445B 5,730B 449B 439B 19,059B EV / Sales 2026 *
2.17x
EV / Sales 2027 * 1.97x
Free-Float
88.34%
Yield 2026 *
5.55%
Yield 2027 * 5.87%
1 day-3.44%
1 week+10.78%
Current month+12.70%
1 month+9.66%
3 months+12.96%
6 months+3.25%
Current year-0.77%
1 week 43
Extreme 43
48.28
1 month 41.5
Extreme 41.5
48.28
Current year 40.8
Extreme 40.8
49.57
1 year 40.8
Extreme 40.8
52.65
3 years 40.8
Extreme 40.8
60.08
5 years 36.99
Extreme 36.988
60.08
10 years 36.99
Extreme 36.988
60.08
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer 51 11/09/2023
Director TitleAgeSince
Director/Board Member 60 30/04/2019
Director/Board Member 57 28/04/2020
Director/Board Member 65 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-3.44%+10.78% - - 106B
+0.25%-3.96%+68.73%+120.06% 1,055B
+0.78%+0.21%+48.53%+50.78% 632B
+0.35%+0.95%+21.11%+66.86% 442B
+1.08%-2.36%+40.70%+41.23% 351B
+0.58%-1.41%+23.81%+38.81% 290B
+0.38%-1.98%-1.09%+8.93% 243B
+1.00%+0.52%+41.46%+58.95% 227B
-0.25%-5.13%-16.13%-53.41% 200B
+0.40%+4.40%+17.36%+81.59% 172B
Average +0.11%-1.44%+27.16%+45.98% 401.39B
Weighted average by Cap. +0.38%-1.87%+39.47%+64.47%

Financials

2026 *2027 *
Net sales 47.59B 55.13B 44.65B 40.67B 76.47B 5,271B 77.53B 523B 205B 2,641B 207B 202B 8,784B 50.7B 58.73B 47.57B 43.33B 81.47B 5,616B 82.6B 558B 219B 2,813B 221B 216B 9,359B
Net income 7.94B 9.2B 7.45B 6.79B 12.76B 880B 12.94B 87.33B 34.22B 441B 34.54B 33.79B 1,466B 9.27B 10.73B 8.69B 7.92B 14.89B 1,026B 15.1B 102B 39.94B 514B 40.3B 39.43B 1,710B
Net Debt 11.42B 13.22B 10.71B 9.75B 18.34B 1,264B 18.6B 126B 49.2B 633B 49.64B 48.57B 2,107B 8.23B 9.54B 7.72B 7.03B 13.23B 912B 13.41B 90.54B 35.48B 457B 35.8B 35.03B 1,520B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
17/08/26 $44.33 +1.56% 2,003
14/08/26 $43.65 -0.65% 201,049
13/08/26 $43.94 +0.77% 1,400
12/08/26 $43.60 -0.02% 967
11/08/26 $43.61 +0.07% 558
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
76.66EUR
Average target price
94.28EUR
Spread / Average Target
+22.98%

Quarterly revenue - Rate of surprise